Jack Meehan
Stock Analyst at Barclays
(3.10)
# 1,197
Out of 4,876 analysts
136
Total ratings
70.73%
Success rate
21.1%
Average return
Main Sectors:
Stocks Rated by Jack Meehan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LH Labcorp Holdings | Maintains: Equal-Weight | $250 → $275 | $260.59 | +5.53% | 16 | Jun 25, 2025 | |
| A Agilent Technologies | Maintains: Underweight | $120 → $125 | $119.17 | +4.89% | 20 | Feb 28, 2024 | |
| WAT Waters | Maintains: Equal-Weight | $275 → $288 | $352.41 | -18.28% | 10 | Aug 3, 2023 | |
| AVTR Avantor | Initiates: Overweight | $33 | $13.53 | +143.90% | 3 | Mar 3, 2021 | |
| ILMN Illumina | Initiates: Underweight | $325 | $94.79 | +242.86% | 8 | Mar 3, 2021 | |
| INMD InMode | Maintains: Overweight | $18 → $19 | $14.19 | +33.90% | 3 | Aug 17, 2020 | |
| DGX Quest Diagnostics | Maintains: Equal-Weight | $93 → $99 | $177.83 | -44.33% | 7 | Apr 23, 2020 | |
| ICLR ICON Public Limited Company | Maintains: Overweight | $170 → $180 | $144.56 | +24.52% | 2 | Apr 23, 2020 | |
| MYGN Myriad Genetics | Maintains: Underweight | $14 → $10 | $5.25 | +90.48% | 8 | Mar 26, 2020 | |
| IQV IQVIA Holdings | Maintains: Overweight | $192 → $166 | $157.47 | +5.42% | 4 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $51 → $43 | $65.01 | -33.86% | 9 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $170 → $154 | $150.01 | +2.66% | 7 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $435 → $430 | $243.98 | +76.24% | 6 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $435 → $430 | $242.60 | +77.25% | 6 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | n/a | $28.87 | - | 10 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $52 → $48 | $41.80 | +14.83% | 4 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $720 → $680 | $1,184.54 | -42.59% | 4 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $28 → $30 | $109.58 | -72.62% | 3 | Oct 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $295 → $300 | $408.28 | -26.52% | 5 | Mar 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $40 | $1.49 | +2,584.56% | 1 | Dec 11, 2017 |
Labcorp Holdings
Jun 25, 2025
Maintains: Equal-Weight
Price Target: $250 → $275
Current: $260.59
Upside: +5.53%
Agilent Technologies
Feb 28, 2024
Maintains: Underweight
Price Target: $120 → $125
Current: $119.17
Upside: +4.89%
Waters
Aug 3, 2023
Maintains: Equal-Weight
Price Target: $275 → $288
Current: $352.41
Upside: -18.28%
Avantor
Mar 3, 2021
Initiates: Overweight
Price Target: $33
Current: $13.53
Upside: +143.90%
Illumina
Mar 3, 2021
Initiates: Underweight
Price Target: $325
Current: $94.79
Upside: +242.86%
InMode
Aug 17, 2020
Maintains: Overweight
Price Target: $18 → $19
Current: $14.19
Upside: +33.90%
Quest Diagnostics
Apr 23, 2020
Maintains: Equal-Weight
Price Target: $93 → $99
Current: $177.83
Upside: -44.33%
ICON Public Limited Company
Apr 23, 2020
Maintains: Overweight
Price Target: $170 → $180
Current: $144.56
Upside: +24.52%
Myriad Genetics
Mar 26, 2020
Maintains: Underweight
Price Target: $14 → $10
Current: $5.25
Upside: +90.48%
IQVIA Holdings
Mar 26, 2020
Maintains: Overweight
Price Target: $192 → $166
Current: $157.47
Upside: +5.42%
Mar 26, 2020
Maintains: Equal-Weight
Price Target: $51 → $43
Current: $65.01
Upside: -33.86%
Mar 26, 2020
Maintains: Equal-Weight
Price Target: $170 → $154
Current: $150.01
Upside: +2.66%
Mar 26, 2020
Maintains: Overweight
Price Target: $435 → $430
Current: $243.98
Upside: +76.24%
Mar 26, 2020
Maintains: Overweight
Price Target: $435 → $430
Current: $242.60
Upside: +77.25%
Mar 26, 2020
Downgrades: Equal-Weight
Price Target: n/a
Current: $28.87
Upside: -
Mar 26, 2020
Upgrades: Overweight
Price Target: $52 → $48
Current: $41.80
Upside: +14.83%
Mar 26, 2020
Upgrades: Equal-Weight
Price Target: $720 → $680
Current: $1,184.54
Upside: -42.59%
Oct 2, 2019
Maintains: Underweight
Price Target: $28 → $30
Current: $109.58
Upside: -72.62%
Mar 18, 2019
Maintains: Overweight
Price Target: $295 → $300
Current: $408.28
Upside: -26.52%
Dec 11, 2017
Initiates: Equal-Weight
Price Target: $40
Current: $1.49
Upside: +2,584.56%